Please try another search
For the fiscal year ended 31 December 2010, Advanced Life Sciences Holdings, Inc. revenues decreased 73% to $753K. Net loss applicable to common stockholders increased 2% to $9.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Impairment charge increase from $0K to $2.5M (expense), Interest Income decrease of 28% to $8K (income).
Period Ending: | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | Mar 31, 2010 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0.27 | 0.48 |
Gross Profit | ||||
Operating Income | -3.3 | -1.83 | -1.77 | -1.73 |
Net Income | -3.31 | -2.01 | -2.03 | -1.98 |
Period Ending: | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | Mar 31, 2010 |
---|---|---|---|---|
Total Assets | 0.77 | 4.26 | 3.53 | 6.17 |
Total Liabilities | 10.49 | 11.36 | 13.22 | 13.9 |
Total Equity | -9.72 | -7.1 | -9.69 | -7.73 |
Period Ending: | Dec 31, 2010 | Sep 30, 2010 | Jun 30, 2010 | Mar 31, 2010 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -6.43 | -5.39 | -3.43 | -2.3 |
Cash From Investing Activities | 0 | 0 | 0 | 0 |
Cash From Financing Activities | 3.75 | 3.49 | 0.68 | 2.25 |
Net Change in Cash | -2.68 | -1.89 | -2.76 | -0.05 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review